Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration

BACKGROUND: Tumor spreading is the major threat for cancer patients. The recently published anti-cancer drug salinomycin raised hope for an improved treatment by targeting therapy-refractory cancer stem cells. However, an unambiguous role of salinomycin against cancer cell migration and metastasis f...

Descripción completa

Detalles Bibliográficos
Autores principales: Kopp, Florian, Hermawan, Adam, Oak, Prajakta Shirish, Herrmann, Annika, Wagner, Ernst, Roidl, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909296/
https://www.ncbi.nlm.nih.gov/pubmed/24468090
http://dx.doi.org/10.1186/1476-4598-13-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909296/
https://www.ncbi.nlm.nih.gov/pubmed/24468090
http://dx.doi.org/10.1186/1476-4598-13-16

Ejemplares similares